BioGX

Oct

BioGX Launches 5 new CE Mark IVD Tests, Expands Number of Sexual Health Panels

Amsterdam, The Netherlands, 23 October 2018 – BioGX B.V. recently released 5 new sexual health CE Mark IVD tests, expanding BioGX’s CE-IVD menu to a total of 21 multiplex panels, with...

May

BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance

Amsterdam, The Netherlands, 24 May 2018 – BioGX B.V. continues its *BD MAX menu expansion with the launch of six additional CE-Mark infectious disease tests on Becton, Dickinson and...

Feb

BioGX and Launch Diagnostics Announce Distribution Partnership For U.K. and Ireland

BIRMINGHAM, Ala., Feb. 8, 2018 /PRNewswire/ -- BioGX continues to expand its global presence with the announcement of a distribution partnership between BioGX's Amsterdam-based European...

Feb

BioGX BV and AxonLab AG Announce Distribution Partnership

BIRMINGHAM, Ala., Feb. 6, 2018 /PRNewswire/ -- BioGX continues to expand its international presence with the announcement of a new strategic partnership between BioGX's Amsterdam-based...

What's New at BioGX

BioGX Launches 5 new CE Mark IVD Tests, Expands Number of Sexual Health Panels

BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance

BioGX and Launch Diagnostics Announce Distribution Partnership For U.K. and Ireland

BioGX BV and AxonLab AG Announce Distribution Partnership

There is currently no news to display